Dechra Pharmaceuticals (DPH.L) Financials

£1.9 B

Mkt cap, 31-Oct-2017

£247.6 M

Revenue FY, 2016
Revenue growth (FY, 2015 - FY, 2016), %22%
Gross profit (FY, 2016)132.4 M
Gross profit margin (FY, 2016), %53.5%
Net income (FY, 2016)12.5 M
Cash, 30-Jun-201639.1 M

Revenue/Financials

Income Statement

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

189.2 m193.6 m203.5 m247.6 m

Revenue growth, %

2%5%22%

Cost of goods sold

88.5 m85.9 m87.3 m115.1 m

Gross profit

100.7 m107.7 m116.1 m132.4 m

Gross profit Margin, %

53%56%57%53%

Pre tax profit

21.4 m25.8 m14.5 m

Net Income

19.4 m19.5 m12.5 m

Balance Sheet

Annual

GBPFY, 2014FY, 2015FY, 2016

Cash

26.8 m45.9 m39.1 m

Accounts Receivable

28.3 m27.7 m59.2 m

Current Assets

86.3 m108.6 m162.5 m

PP&E

18.3 m18.2 m37.9 m

Goodwill

196.2 m166.7 m360.4 m

Total Assets

300.8 m293.5 m560.8 m

Accounts Payable

12.9 m10.4 m24.3 m

Current Liabilities

35.7 m44.1 m66.3 m

Total Liabilities

96 m99 m286.1 m

Retained Earnings

6.8 m5.6 m(2.6 m)

Total Equity

204.8 m194.5 m274.6 m

Financial Leverage

1.5 x1.5 x2 x

Cash Flow

Annual

GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

11.5 m41 m43.6 m

Cash From Financing Activities

(92.1 m)(14.8 m)125.3 m

Income Taxes Paid

(2 m)(6.3 m)(2 m)

Ratios

GBPY, 2016

Revenue/Employee

286.9 k

Financial Leverage

2 x
Report incorrect company information